Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1

Interventions

Vinorelbine 3Gemcitabine 3Ifosfamide 2Cyclophosphamide 2zanubrutinib 1treosulfan 1plerixafor 1pegylated granulocyte colony-stimulating factor 1obinutuzumab 1ibritumomab tiuxetan 1fludarabine 1entecavir 1Thiotepa 1Rituximab 1Ice 1Guanosine Diphosphate 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1EPOCH protocol 1Drug Therapy 1Cytarabine 1CVAD protocol 11-(1-glycero)dodeca-1,3,5,7,9-pentaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Lymphoma, Non-Hodgkin × treosulfan × Clear all
NCT01079013 2016-04-20

Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Sheba Medical Center

Phase 2 Unknown
40 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡